NEUROLOGICAL DISEASE

Primary Source of Funding: Kaiser Permanente Innovation Program
Total Project Period: January 2000 – December 2001
Division of Research Principal Investigator: Joseph F. Terdiman, MD, PhD
Description: This project will develop a Web-based computer system to promote early identification and monitoring of the traumatic brain injury population, to assure provision of cost-effective care and optimal clinical management.

Division of Research Principal Investigator: Stephen K. Van Den Eeden, PhD
Primary Source of Funding: Parkinson’s Institute
Total Project Period: April 2000 – March 2002
Description: This is a pilot study to develop diagnostic criteria for dystonia that can be used in large-scale epidemiologic studies. In addition, this study will develop the epidemiologic case identification and confirmation process that can be used in a large managed care organization.

Primary Source of Funding: National Institutes for Health
Total Project Period: September 1996 – May 2004
Division of Research Principal Investigator: Stephen K. Van Den Eden, PhD
Description: To estimate the risk of amyotrophic lateral sclerosis (ALS) associated with exposure to selected putative neirotoxins and genetic polymorphisms of the SOD 1 gene. Seek to estimate incidence of the disease in this population and determine how it may vary by age and gender.

Primary Source of Funding: National Institutes of Health
Total Project Period: September 2000 – April 2004
Division of Research Principal Investigator: Stephen K. Van Den Eeden, PhD
Description: The primary objective of this study is to differentiate the relative risks/benefits of three major AEDs in the treatment of women with epilepsy in terms of their children’s neurobehavioral development after in utero exposure.